Go to Advanced Search
APOE |
LOCUS ID | 348 | |||||||||||||||||||
GENE_SYMBOL | APOE | |||||||||||||||||||
GENE NAME | apolipoprotein E | |||||||||||||||||||
SYNONYMNS | AD2, LPG, LDLCQ5 | |||||||||||||||||||
CHROMOSOME | 19 | |||||||||||||||||||
HOMOLOGENE ID | 30951 |
microRNAs | NA | NA |
GENE SUMMARY |
---|
Chylomicron remnts and very low density lipoprotein (VLDL) remnts are rapidly removed from the circulation by receptor-mediated endocytosis in the liver. Apolipoprotein E, a main apoprotein of the chylomicron, binds to a specific receptor on liver cells and peripheral cells. ApoE is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. The APOE gene is mapped to chromosome 19 in a cluster with APOC1 and APOC2. Defects in apolipoprotein E result in familial dysbetal |
OBSERVATIONS |
---|
Complication | Evidence | PMID |
Nephropathy | 1. In type 2 diabetes, epsilon2 carriers (P = 0.04; odds ratio = 5.42; 95% CI1.10-26.8) and epsilon3/epsilon4 (P = 0.04; odds ratio = 22. 5; 95% CI1.11-454.90) genotype carriers were more likely to have glomerular hypertrophy than were epsilon3/epsilon3 carriers.Our findings confirm the risk association of the ApoE polymorphism with diabetic nephropathy. | 19218599 |
Cardiovascular | 1. Polymorphisms in GYS1 and APOE predict CV mortality in T2D families in a gender-specific fashion and independently of each other | 17356695 |
Retinopathy | 1. epsilon4 allele of the ApoE gene is a potential risk factor for the severity of retinal hard exudates and visual loss in type 2 diabetic Mexican patients with diabetic retinopathy. | 11910554 |
Neuropathy | 1. As the stage of diabetic neuropathy advanced, the incidence of apoE4 increasedApoE phenotype influences the progress of diabetic peripheral neuropathy and that apoE4 contributes to the deterioration of diabetic peripheral neuropathy. | 9760837 |